Monodispersity of recombinant Cre recombinase correlates with its effectiveness in vivo

BMC Biotechnology

Volumn 9, Issue , 2009, Pages 80-

  Capasso, Paola ^a   Aliprandi, Marisa ^a   Ossolengo, Giuseppe ^a   Edenhofer, Frank ^b   De Marco, Ario ^a  

^a IFOM IEO Campus   (Italy)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATION INDEX; BACTERIAL ENDOTOXINS; CELL UPTAKE; CHROMATOGRAPHIC CONDITIONS; CRE RECOMBINASE; CRITICAL STEPS; DATA COMPARISONS; ENZYME DELIVERY; IN-VITRO; IN-VIVO; MONO-DISPERSED; MONODISPERSITY; MULTI-STEP PURIFICATION; OPTIMAL ALTERNATIVE; PURIFICATION PROTOCOL; RECOMBINASE ACTIVITY; REPORTER PROTEIN; SPECIFIC ACTIVITY; SPECTROFLUORIMETRIC; STRONG CORRELATION; TARGET GENES;

BACTERIOLOGY; DESALINATION; ENZYMES; METAL IONS; METAL RECOVERY; METAL REFINING; OPTIMIZATION; PURIFICATION;

ENZYME ACTIVITY;

BETA CATENIN; CRE RECOMBINASE; ENDOTOXIN; TRANSACTIVATOR PROTEIN; CATENIN; HYBRID PROTEIN; INTEGRASE;

ARTICLE; BIOTECHNOLOGICAL PROCEDURES; CONTROLLED STUDY; DISPERSION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME KINETICS; ENZYME PURIFICATION; IN VIVO STUDY; PROTEIN AGGREGATION; SPECTROFLUOROMETRY; CELL CULTURE; CHROMATOGRAPHY; COMPARATIVE STUDY; GENETIC ENGINEERING; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN FOLDING;

BACTERIA (MICROORGANISMS);

CATENINS; CELLS, CULTURED; CHROMATOGRAPHY; ENDOTOXINS; GENETIC ENGINEERING; INTEGRASES; PROTEIN FOLDING; RECOMBINANT FUSION PROTEINS;

EID: 70350726751     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-9-80     Document Type: Article

References (25)

1. Buchholz F, Ringrose L, Angrand P-O, Rossi F, Stewart AF. Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination. Nucleic Acids Res 1996, 24:4256-4262. 10.1093/nar/24.21.4256, 146240, 8932381.
2. Ghosh K, Van Duyne GD. Cre-loxP biochemistry. Methods 2002, 28:374-383. 10.1016/S1046-2023(02)00244-X, 12431441.
3. Cantor EJ, Chong S. Intein-mediated rapid purification of Cre recombinase. Prot Expr Purif 2001, 22:135-140.
4. Park MT, Hwang SJ, Lee GM. Flow cytometric application of helper adenovirus (HAd) containing GFP gene flanked by two parallel loxP sites to evaluation of 293 cre-complementing cell line and monitoring of HAd in Gutless Ad production. Biotechnol Prog 2004, 20:913-920. 10.1021/bp034248e, 15176899.
5. LePage DF, Conlon RA. Animal models for disease: knockout, knock-in, and conditional mutant mice. Methods Mol Med 2006, 129:41-67.
6. Edenhofer F. Protein transduction revisited: novel insights into the mechanism underlying intracellular delivery of proteins. Curr Pharm Des 2008, 14:3628-36. 10.2174/138161208786898833, 19075739.
7. Peitz M, Pfannkuche K, Rajewsky K, Edenhofer F. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc Natl Acad Sci USA 2002, 99:4489-4494. 10.1073/pnas.032068699, 123675, 11904364.
8. Will E, Klump H, Heffner N, Schwieger M, Schiedlmeier B, Ostertag W, Baum C, Stocking C. Unmodified Cre recombinase crosses the membrane. Nucleic Acids Res 2002, 30:e59. 10.1093/nar/gnf059, 117301, 12060697.
9. Lin Q, Jo D, Gebre-Amlak KD, Ruley HE. Enhanced cell-permeant Cre protein for site-specific recombination in cultured cells. BMC Biotechnol 2004, 4:25. 10.1186/1472-6750-4-25, 529453, 15500682.
10. Nominé Y, Ristriani T, Laurent C, Lefevre J-F, Weiss E, Travé G. A strategy for optimizing the monodispersity of fusion proteins: application to purification of recombinant HPV E6 oncoprotein. Prot Engineer 2001, 14:297-305.
11. Schrödel A, de Marco A. Characterization of the aggregates formed during recombinant protein expression in bacteria. BMC Biochem 2005, 6:10. 10.1186/1471-2091-6-10, 1175841, 15927061.
12. Peitz M, Jäger R, Patsch C, Jäger A, Egert A, Schorle H, Edenhofer F. Enhanced purification of cell-permeant Cre and germline transmission after transduction into mouse embryonic stem cells. Genesis 2007, 45:508-517. 10.1002/dvg.20321, 17661398.
13. Liu S, Tobias R, McClure S, Styba G, Shi Q, Jackowski G. Removal of endotoxin from recombinant protein preparations. Clinical Biochem 1997, 30:455-463.
14. Chen RH, Huang C-J, Newton BS, Ritter G, Old LJ, Batt CA. Factors affecting endotoxin removal from recombinant therapeutic proteins by anion exchange chromatography. Prot Expr Purif 2009, 64:76-81.
15. Philo JS. Is any measurement method optimal for all aggregate sizes and types?. AAPS J 2006, 8:E564-E571. 10.1208/aapsj080365, 17025274.
16. Magnusdottir A, Johansson I, Dahlgren L-G, Nordlund P, Berglund H. Enabling IMAC purification of low abundance recombinant proteins from E. coli lysates. Nature Meth 2009, 6:477-478.
17. Jain NK, Roy I. Effect of trehalose on protein structure. Protein Sci 2009, 18:24-36.
18. Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nature Medicine 2004, 10:310-315. 10.1038/nm996, 14770178.
19. Seglen PO, Grinde B, Solheim AE. Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin. Eur J Biochem 1979, 95:215-225. 10.1111/j.1432-1033.1979.tb12956.x, 456353.
20. Caron NJ, Quenneville SP, Tremblay JP. Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins. Biochem Biophys Res Commun 2004, 319:12-20. 10.1016/j.bbrc.2004.04.180, 15158435.
21. Buchholtz F. Principles of site-specific recombinase (SSR) technology. J Vis Exp 2008, 15.
22. Jullien N, Goddard I, Selmi-Ruby S, Fina JL, Cremer H, Herman JP. Conditional transgenesis using Dimerizable Cre (DiCre). PLoS One 2007, 2:e1355. 10.1371/journal.pone.0001355, 2131782, 18159238.
23. Gelato KA, Martin SS, Liu PH, Saunders AA, Baldwin EP. Spatially directed assembly of a heterotetrameric Cre-Lox synapse restricts recombination specificity. J Mol Biol 2008, 378:653-665. 10.1016/j.jmb.2008.02.058, 2418607, 18374357.
24. Warren D, Laxmikanthan G, Landy A. A chimeric Cre recombinase with regulated directionality. Proc Natl Acad Sci USA 2008, 105:18278-18283. 10.1073/pnas.0809949105, 2587618, 19011106.
25. Edwards WF, Young DD, Deiters A. Light-activated Cre recombinase as a tool for the spatial and temporal control of gene function in mammalian cells. ACS Chem Biol 2009, 4:441-445. 10.1021/cb900041s, 19413301.